Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

JNJ PFE NVS SNY Aluminum Drugs Rentals Large Value 
Benchmark SP 500  1,652   12.77  Index Moved Up 0.78% United States ...


Processing
Processing. Please wait...

Pfizer Number of Shares Shorted

 
 Companies |  Insiders  | Dashboard  
     
Number of Shares Shorted is total amount of shares that are currently sold short by investors. When stock is sold short, the short seller assumes the responsibility of buying the stock back at a lower price. The speculator will make money if the stock goes down in price or will experience loss if the stock price goes up.

Pfizer

Shares Shorted

=

Shorted by Public

+

by Institutions

=
55.24 M
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect price of the stock.
Compare Pfizer to competition

Pfizer Number of Shares Shorted Assessment

Based on recorded statements Pfizer Inc has 55.24 M of outstending shares currently sold short by investors. This is 1539.73% higher than that of Healthcare sector, and 638.0% higher than that of Drug Manufacturers - Major industry, The Number of Shares Shorted for all stocks is 2412.89% lower than the firm.

Filter other Stocks by Number of Shares Shorted

Select Number of Shares Shorted Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  
Pfizer is regarded second in number of shares shorted category among related companies.
Follow Pfizer Number of Shares Shorted with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Pfizer to your reader
 
    
PFE United States NYSE
Pfizer Inc
Benchmark S&P 500
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
    

Other Pfizer Fundamentals

Return On Equity12.68 %
Return On Asset6.22 %
Profit Margin26.95 %
Operating Margin32.20 %
Current Valuation206.74 B
Shares Outstanding7.09 B
Shares Owned by Insiders0.02 %
Shares Owned by Institutions72.60 %
Number of Shares Shorted55.24 M
Price to Earning13.93 times
Price to Book2.51 times
Price to Sales3.58 times
Revenue57.6 B
Gross Profit47.65 B
EBITDA25.34 B
Net Income10.52 B
Cash and Equivalents35.41 B
Cash per Share4.99 times
Total Debt40.4 B
Debt to Equity0.49 times
Current Ratio2.35 times
Book Value Per Share11.59 times
Cash Flow from Operations16.52 B
Short Ratio2.00 times
One Year High31.15
One Year Low22.0
Earnings Per Share2.09 times
Price to Earnings To Growth4.82 times
Number of Employees89.4 K
Beta0.74
Market Capitalization206.34 B
Total Asset187.4 B
Retained Earnings56.97 B
Working Capital37.22 B
Current Asset64.76 B
Current Liabilities27.54 B
Z Score3.0
Probability Of Bankruptcy29.00 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium